Literature DB >> 29474331

Candidemia in the ICU: Does Initial Antifungal Matter?

John E Bennett1, John H Powers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29474331      PMCID： PMC5920524          DOI： 10.1097/CCM.0000000000002903

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  14 in total

1.  Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.

Authors:  José Garnacho-Montero; Ana Díaz-Martín; Luisa Cantón-Bulnes; Paula Ramírez; Rafael Sierra; Dolores Arias-Verdú; Marina Rodríguez-Delgado; Ana Loza-Vázquez; Jesús Rodriguez-Gomez; Mónica Gordón; Ángel Estella; José Luis García-Garmendia
Journal:  Crit Care Med       Date:  2018-03       Impact factor: 7.598

2.  Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.

Authors:  M Fernández-Ruiz; J Guinea; D Lora-Pablos; Ó Zaragoza; M Puig-Asensio; B Almirante; M Cuenca-Estrella; J M Aguado
Journal:  Clin Microbiol Infect       Date:  2017-01-29       Impact factor: 8.067

3.  Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort.

Authors:  L E López-Cortés; B Almirante; M Cuenca-Estrella; J Garnacho-Montero; B Padilla; M Puig-Asensio; I Ruiz-Camps; J Rodríguez-Baño
Journal:  Clin Microbiol Infect       Date:  2016-05-14       Impact factor: 8.067

4.  A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.

Authors:  Matteo Bassetti; Elda Righi; Filippo Ansaldi; Maria Merelli; Cecilia Trucchi; Trucchi Cecilia; Gennaro De Pascale; Ana Diaz-Martin; Roberto Luzzati; Chiara Rosin; Leonel Lagunes; Enrico Maria Trecarichi; Maurizio Sanguinetti; Brunella Posteraro; Jose Garnacho-Montero; Assunta Sartor; Jordi Rello; Giorgio Della Rocca; Massimo Antonelli; Mario Tumbarello
Journal:  Intensive Care Med       Date:  2014-05-08       Impact factor: 17.440

5.  Determinants of mortality in non-neutropenic ICU patients with candidaemia.

Authors:  Deborah J E Marriott; E Geoffrey Playford; Sharon Chen; Monica Slavin; Quoc Nguyen; David Ellis; Tania C Sorrell
Journal:  Crit Care       Date:  2009-07-13       Impact factor: 9.097

6.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors:  Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

7.  Anidulafungin versus fluconazole for invasive candidiasis.

Authors:  Annette C Reboli; Coleman Rotstein; Peter G Pappas; Stanley W Chapman; Daniel H Kett; Deepali Kumar; Robert Betts; Michele Wible; Beth P Goldstein; Jennifer Schranz; David S Krause; Thomas J Walsh
Journal:  N Engl J Med       Date:  2007-06-14       Impact factor: 91.245

8.  Initial antifungal strategy does not correlate with mortality in patients with candidemia.

Authors:  R Murri; G Scoppettuolo; G Ventura; M Fabbiani; F Giovannenze; F Taccari; E Milozzi; B Posteraro; M Sanguinetti; R Cauda; M Fantoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-03       Impact factor: 3.267

9.  Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis.

Authors:  Francisco J González de Molina; Cristóbal León; Sergio Ruiz-Santana; Pedro Saavedra
Journal:  Crit Care       Date:  2012-06-14       Impact factor: 9.097

10.  Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period.

Authors:  Arnaldo L Colombo; Thais Guimarães; Teresa Sukienik; Alessandro C Pasqualotto; Ricardo Andreotti; Flavio Queiroz-Telles; Simone A Nouér; Marcio Nucci
Journal:  Intensive Care Med       Date:  2014-08-01       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.